{"article":{"annotation":{"article_id":"goa-life-course-immunization-policy-research-2026","available_at":"2026-10-07T03:14:17.442701Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"3bf47d2bf044d6745c33738c6fd7ca4600b087100afeb0ff59242002d85e92f3","input_sha256":"93bd2b33d5048868ea2a3a8259b6982e522aecb8c5eb43eadffdee114bdb3e36","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[{"admin1":null,"city":null,"coordinate_note":null,"coordinate_reference_system":"OGC:CRS84","coordinate_source":null,"country":"IN","evidence":[{"field":"country","language":"en","note":"Explicit preserved editorial country/region; no city or national centroid inferred","source_urls":["https://ahpsr.who.int/newsroom/news/item/02-10-2026-research-at-the-policy-table-how-goa-built-india-s-first-dedicated-life-course-immunization-policy","https://www.goa.gov.in/wp-content/uploads/2026/09/646.pdf"]}],"geometry":null,"id":"iso3166-1:IN","kind":"country-or-area","labels":{"ar":"الهند","en":"India","es":"India","fr":"Inde"},"match_status":"candidate","precision":"regional","role":"coverage","uncertainty_m":null}],"rules_sha256":"d28c9c89703b56bd91fd887965d416d0115c2473d4bfbd3e558bcceafc3941dd","schema_version":1,"subjects":[{"concept_id":"medtop:20000448","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: influenza","source_urls":["https://ahpsr.who.int/newsroom/news/item/02-10-2026-research-at-the-policy-table-how-goa-built-india-s-first-dedicated-life-course-immunization-policy","https://www.goa.gov.in/wp-content/uploads/2026/09/646.pdf"]}],"method":"controlled-rules-v1","rule_id":"communicable-disease","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026?lang=fr","category":"health","content":{"key_points":[],"paragraphs":["Le 23 septembre, l’État indien de Goa a annoncé être le premier du pays à adopter une politique dédiée à la vaccination tout au long de la vie. Le cadre 2026–2036 vise à intégrer la vaccination des adultes aux soins courants au-delà de l’enfance. Dans un article publié le 2 octobre, l’Alliance de l’Organisation mondiale de la Santé pour la recherche sur les politiques et les systèmes de santé a indiqué que la première phase de mise en œuvre proposerait les vaccins contre la grippe, le pneumocoque et l’hépatite B aux adultes admissibles, notamment aux personnes atteintes de maladies chroniques, immunodéprimées et aux professionnels de santé.","L’Alliance décrit un processus de recherche dans lequel le gouvernement de Goa a travaillé avec des chercheurs du Goa Institute of Management et d’Oxford Policy Management (Inde) pour prendre en compte les risques cliniques et les capacités du système de santé existant. Le communiqué de lancement de l’État cite également ces trois vaccins pour la phase initiale et prévoit leur intégration aux services actuels. Les sources décrivent un plan de déploiement ; elles ne donnent pas encore de résultats sur les doses administrées, la participation, la couverture ou l’efficacité en conditions réelles."],"sections":[]},"corrections":[{"at":"2026-10-07T00:49:30+03:00","language":"fr","text":"Des éditions allemande et portugaise, ainsi que les traductions des explications des données et des corrections, ont été ajoutées à cet article."},{"at":"2026-10-07T05:57:45+03:00","language":"fr","text":"Classification des données corrigée : les identifiants et les types de mesure suivent désormais les règles du jeu de données. Aucun chiffre, unité ou date n’a changé."}],"country":"IN","data":{"blocks":[{"description":{"ar":"أنواع اللقاحات المدرجة للمرحلة التنفيذية الأولى من إطار السياسة 2026–2036 الذي أُعلن في 23 سبتمبر 2026.","de":"Impfstoffarten für die erste Umsetzungsphase des am 23. September 2026 angekündigten politischen Rahmens für 2026–2036.","en":"Vaccine types listed for the initial implementation phase of the 2026–2036 policy framework announced on 23 September 2026.","es":"Tipos de vacunas enumerados para la fase inicial de aplicación del marco político 2026–2036 anunciado el 23 de septiembre de 2026.","fr":"Types de vaccins indiqués pour la première phase de mise en œuvre du cadre politique 2026–2036 annoncé le 23 septembre 2026.","pt":"Tipos de vacina listados para a fase inicial de implementação da política de 2026–2036 anunciada em 23 de setembro de 2026.","tr":"23 Eylül 2026'da açıklanan 2026–2036 politika çerçevesinin ilk uygulama aşamasında kaynakların sıraladığı aşı türleri."},"id":"goa-first-phase-vaccine-types","items":[{"basis":"target","label":{"ar":"أنواع اللقاحات المدرجة للتنفيذ الأولي: الإنفلونزا والمكورات الرئوية والتهاب الكبد B","de":"Für die erste Umsetzung vorgesehene Impfstoffe: Influenza, Pneumokokken und Hepatitis B","en":"Vaccine types listed for initial implementation: influenza, pneumococcal and hepatitis B","es":"Tipos de vacunas indicados para la aplicación inicial: gripe, neumococo y hepatitis B","fr":"Types de vaccins inscrits pour la mise en œuvre initiale : grippe, pneumocoque et hépatite B","pt":"Tipos de vacina previstos para a implementação inicial: influenza, pneumococo e hepatite B","tr":"İlk uygulama aşamasında listelenen aşı türü sayısı: grip, pnömokok ve hepatit B"},"measure":{"aggregation":"stock","frequency":"irregular","geography":"goa-india","id":"goa-initial-adult-immunisation-vaccine-types","periodRole":"announcement-date","unitCode":"count"},"period":"2026-09-23","unit":"count","value":3}],"methodology":{"ar":"يحصي هذا المؤشر أنواع اللقاحات المختلفة المذكورة للمرحلة الأولى في السياسة والإرشادات التشغيلية؛ ولا يمثل عدد الجرعات أو كمية الشراء أو عدد الأشخاص المطعّمين أو التغطية المحققة. وتشمل الفئات ذات الأولوية البالغين المؤهلين وفق نهج قائم على المخاطر، ومنهم المصابون بأمراض مزمنة وضعيفو المناعة والعاملون الصحيون.","de":"Gezählt werden die unterschiedlichen Impfstoffarten, die in Politik und operativer Anleitung für die erste Phase genannt werden; es handelt sich nicht um Dosen, Beschaffungsmengen, Zahl geimpfter Personen oder erreichte Abdeckung. Vorranggruppen sind nach Risiko ausgewählte Erwachsene, darunter Menschen mit chronischen Erkrankungen, immungeschwächte Patientinnen und Patienten sowie Beschäftigte im Gesundheitswesen.","en":"This counts the distinct vaccine types named for the initial phase in the policy and operational guidance; it is not a dose count, procurement volume, number of vaccinated people or achieved coverage. Priority groups are eligible adults selected by risk, including people with chronic disease, immunocompromised patients and health workers.","es":"Este indicador cuenta los tipos de vacunas distintos incluidos para la fase inicial en la política y las directrices operativas; no es un recuento de dosis, volumen de compra, personas vacunadas ni cobertura alcanzada. Los grupos prioritarios son adultos elegibles seleccionados según el riesgo, incluidas personas con enfermedades crónicas, inmunodeprimidas y trabajadores de la salud.","fr":"Cet indicateur compte les types de vaccins distincts mentionnés pour la phase initiale dans la politique et les directives opérationnelles ; il ne s’agit ni d’un nombre de doses, ni d’un volume d’achat, ni d’un nombre de personnes vaccinées, ni d’une couverture atteinte. Les groupes prioritaires sont les adultes admissibles sélectionnés selon le risque, notamment les personnes atteintes de maladies chroniques, immunodéprimées et les professionnels de santé.","pt":"Contam-se os tipos distintos de vacina mencionados na política e nas orientações operacionais para a fase inicial; não se trata de doses, volumes de aquisição, número de pessoas vacinadas nem cobertura alcançada. Os grupos prioritários são adultos selecionados por risco, incluindo pessoas com doenças crônicas, pacientes imunocomprometidos e profissionais de saúde.","tr":"Bu gösterge, politika ve operasyonel yönergede ilk aşama için sayılan farklı aşı türlerinin adedidir; doz, doz sayısı, satın alma miktarı, aşılanan kişi veya gerçekleşmiş kapsam değildir. Öncelikli hedef gruplar, kronik hastalığı olanlar, bağışıklığı baskılanmış kişiler ve sağlık çalışanları dahil risk temelli uygun yetişkinlerdir."},"sourceUrls":["https://ahpsr.who.int/newsroom/news/item/02-10-2026-research-at-the-policy-table-how-goa-built-india-s-first-dedicated-life-course-immunization-policy","https://www.goa.gov.in/wp-content/uploads/2026/09/646.pdf"],"title":{"ar":"المرحلة الأولى من سياسة غوا للتطعيم مدى الحياة","de":"Erste Phase von Goas Impfpolitik für den gesamten Lebensverlauf","en":"First phase of Goa’s life-course immunisation policy","es":"Primera fase de la política de inmunización a lo largo de la vida de Goa","fr":"Première phase de la politique de vaccination tout au long de la vie de Goa","pt":"Fase inicial da política de imunização de Goa ao longo da vida","tr":"Goa'nın yaşam boyu bağışıklama politikasının ilk aşaması"},"type":"metrics","updatedAt":"2026-10-07T00:49:30+03:00"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026/data/goa-first-phase-vaccine-types?lang=fr&format=csv","json":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026/data/goa-first-phase-vaccine-types?lang=fr&format=json"},"id":"goa-first-phase-vaccine-types"}],"data_types":["metrics"],"editorial_illustration":{"alt":"Illustration conceptuelle de la santé publique, de la recherche et des données connectées.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"fr","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"event_id":"event-b17a4029-9014-5d63-af92-af3101b5e10a","event_period":"2026-09-23","event_period_basis":"event-or-reference-period","id":"goa-life-course-immunization-policy-research-2026","image":null,"importance":0.6,"language":"fr","modified_at":"2026-10-07T05:57:45+03:00","publication_basis":"publication-record","published_at":"2026-10-04T14:04:24+00:00","reading_minutes":2,"region":"world","section_illustration":{"alt":"Illustration conceptuelle de la santé publique, de la recherche et des données connectées.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"fr","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"slug":"goa-life-course-immunization-policy-research-2026","sources":[{"checkedAt":"2026-10-04","name":"WHO Alliance for Health Policy and Systems Research","publishedAt":"2026-10-02","url":"https://ahpsr.who.int/newsroom/news/item/02-10-2026-research-at-the-policy-table-how-goa-built-india-s-first-dedicated-life-course-immunization-policy"},{"checkedAt":"2026-10-04","name":"Department of Information & Publicity, Government of Goa","publishedAt":"2026-09-23","url":"https://www.goa.gov.in/wp-content/uploads/2026/09/646.pdf"}],"summary":"Goa a lancé une politique de vaccination tout au long de la vie pour 2026–2036. Sa première phase proposera les vaccins contre la grippe, le pneumocoque et l’hépatite B à des groupes adultes à risque.","text":"Goa a lancé une politique de vaccination tout au long de la vie pour 2026–2036. Sa première phase proposera les vaccins contre la grippe, le pneumocoque et l’hépatite B à des groupes adultes à risque.\n\nLe 23 septembre, l’État indien de Goa a annoncé être le premier du pays à adopter une politique dédiée à la vaccination tout au long de la vie. Le cadre 2026–2036 vise à intégrer la vaccination des adultes aux soins courants au-delà de l’enfance. Dans un article publié le 2 octobre, l’Alliance de l’Organisation mondiale de la Santé pour la recherche sur les politiques et les systèmes de santé a indiqué que la première phase de mise en œuvre proposerait les vaccins contre la grippe, le pneumocoque et l’hépatite B aux adultes admissibles, notamment aux personnes atteintes de maladies chroniques, immunodéprimées et aux professionnels de santé.\n\nL’Alliance décrit un processus de recherche dans lequel le gouvernement de Goa a travaillé avec des chercheurs du Goa Institute of Management et d’Oxford Policy Management (Inde) pour prendre en compte les risques cliniques et les capacités du système de santé existant. Le communiqué de lancement de l’État cite également ces trois vaccins pour la phase initiale et prévoit leur intégration aux services actuels. Les sources décrivent un plan de déploiement ; elles ne donnent pas encore de résultats sur les doses administrées, la participation, la couverture ou l’efficacité en conditions réelles.\n\nDes éditions allemande et portugaise, ainsi que les traductions des explications des données et des corrections, ont été ajoutées à cet article.\n\nClassification des données corrigée : les identifiants et les types de mesure suivent désormais les règles du jeu de données. Aucun chiffre, unité ou date n’a changé.","title":"Goa intègre la vaccination des adultes dans une politique couvrant tout le parcours de vie","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/goa-life-course-immunization-policy-research-2026"},{"api_url":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026?lang=en","language":"en","url":"https://newsverum.com/en/news/goa-life-course-immunization-policy-research-2026"},{"api_url":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/goa-life-course-immunization-policy-research-2026"},{"api_url":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/goa-life-course-immunization-policy-research-2026"},{"api_url":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026?lang=es","language":"es","url":"https://newsverum.com/es/news/goa-life-course-immunization-policy-research-2026"},{"api_url":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026?lang=de","language":"de","url":"https://newsverum.com/de/news/goa-life-course-immunization-policy-research-2026"},{"api_url":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/goa-life-course-immunization-policy-research-2026"}],"url":"https://newsverum.com/fr/news/goa-life-course-immunization-policy-research-2026"},"version":"1"}